Figure 3From: Effect of TTP488 in patients with mild to moderate Alzheimer’s disease TTP488 plasma concentration over time. On-treatment data where on-treatment is defined as plasma concentrations measured within 45 days of last administered dose. Data presented as mean values with 95% confidence boundary. For the 20 mg/day group data presented through Month 15 after which there were too few observations.Back to article page